Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Chem Neurosci
2014 May 21;55:346-59. doi: 10.1021/cn4002297.
Show Gene links
Show Anatomy links
Discovery of potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL.
Bürgi JJ
,
Awale M
,
Boss SD
,
Schaer T
,
Marger F
,
Viveros-Paredes JM
,
Bertrand S
,
Gertsch J
,
Bertrand D
,
Reymond JL
.
???displayArticle.abstract???
While a plethora of ligands are known for the well studied α7 and α4β2 nicotinic acetylcholine receptor (nAChR), only very few ligands address the related α3β2 nAChR expressed in the central nervous system and at the neuromuscular junction. Starting with the public database ChEMBL organized in the chemical space of Molecular Quantum Numbers (MQN, a series of 42 integer value descriptors of molecular structure), a visual survey of nearest neighbors of the α7 nAChR partial agonist N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) pointed to N-(2-halobenzyl)-3-aminoquinuclidines as possible nAChR modulators. This simple "chemical space walk" was performed using a web-browser available at www.gdb.unibe.ch . Electrophysiological recordings revealed that these ligands represent a new and to date most potent class of positive allosteric modulators (PAMs) of the α3β2 nAChR, which also exert significant effects in vivo. The present discovery highlights the value of surveying chemical space neighbors of known drugs within public databases to uncover new pharmacology.
Abdel-Magid,
Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).
1996, Pubmed
Abdel-Magid,
Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).
1996,
Pubmed
Awale,
Cluster analysis of the DrugBank chemical space using molecular quantum numbers.
2012,
Pubmed
Bajorath,
Modeling of activity landscapes for drug discovery.
2012,
Pubmed
Bartos,
Glutamine 57 at the complementary binding site face is a key determinant of morantel selectivity for {alpha}7 nicotinic receptors.
2009,
Pubmed
Blum,
Visualisation and subsets of the chemical universe database GDB-13 for virtual screening.
2011,
Pubmed
Blum,
Discovery of α7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13.
2011,
Pubmed
,
Xenbase
Bodnar,
Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.
2005,
Pubmed
Bohacek,
The art and practice of structure-based drug design: a molecular modeling perspective.
1996,
Pubmed
Bréthous,
Synthesis and nicotinic receptor activity of chemical space analogues of N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) and 1,4-diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester (SSR180711).
2012,
Pubmed
,
Xenbase
Brioni,
Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test.
1993,
Pubmed
Cesa,
Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiation.
2012,
Pubmed
D'hoedt,
Nicotinic acetylcholine receptors: an overview on drug discovery.
2009,
Pubmed
Fagerlund,
Current concepts in neuromuscular transmission.
2009,
Pubmed
Garcia-Delgado,
Exploring α7-Nicotinic Receptor Ligand Diversity by Scaffold Enumeration from the Chemical Universe Database GDB.
2010,
Pubmed
,
Xenbase
Gaulton,
ChEMBL: a large-scale bioactivity database for drug discovery.
2012,
Pubmed
Gottlieb,
NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities.
1997,
Pubmed
Hogg,
An automated system for intracellular and intranuclear injection.
2008,
Pubmed
,
Xenbase
Lipinski,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
2001,
Pubmed
Nguyen,
Classification of organic molecules by molecular quantum numbers.
2009,
Pubmed
Oprea,
Chemography: the art of navigating in chemical space.
2001,
Pubmed
Renner,
Recent trends and observations in the design of high-quality screening collections.
2011,
Pubmed
Reymond,
Exploring chemical space for drug discovery using the chemical universe database.
2012,
Pubmed
Reymond,
Exploring the chemical space of known and unknown organic small molecules at www.gdb.unibe.ch.
2011,
Pubmed
Ruddigkeit,
Visualization and virtual screening of the chemical universe database GDB-17.
2013,
Pubmed
Ruddigkeit,
Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17.
2012,
Pubmed
Seo,
The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase
Tsuneki,
Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle.
1995,
Pubmed
Turner,
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
2010,
Pubmed
van Deursen,
Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem.
2011,
Pubmed
van Deursen,
A searchable map of PubChem.
2010,
Pubmed
Vicens,
Motor and anxiety effects of PNU-282987, an alpha7 nicotinic receptor agonist, and stress in an animal model of Alzheimer's disease.
2013,
Pubmed
Wallace,
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.
2011,
Pubmed
,
Xenbase
Wang,
PubChem: a public information system for analyzing bioactivities of small molecules.
2009,
Pubmed
Wu,
Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.
2008,
Pubmed
,
Xenbase
